Patients With Rheumatoid Arthritis With an Inadequate Response to Disease‐Modifying Antirheumatic Drugs at a Higher Risk of Acute Coronary Syndrome

BACKGROUND: Cardiovascular disease is the most common cause of death in patients with rheumatoid arthritis. It is believed that using disease‐modifying antirheumatic drugs (DMARDs) to control inflammation can reduce the risk of cardiovascular disease. In this study, we investigated whether patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Chung‐Yuan, Su, Yu‐Jih, Chen, Jia‐Feng, Sun, Chi‐Chin, Cheng, Tien‐Tsai, Tsai, Tzu‐Hsien, Lin, Shang‐Hong, Chang, Cheng‐Chieh, Chen, Tien‐Hsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174161/
https://www.ncbi.nlm.nih.gov/pubmed/33860677
http://dx.doi.org/10.1161/JAHA.120.018290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174161/
https://www.ncbi.nlm.nih.gov/pubmed/33860677
http://dx.doi.org/10.1161/JAHA.120.018290

Ejemplares similares